Please Wait
Applying Filters...
Menu

Digital content

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

    https://www.pharmacompass.com/pdf/party/content/tiefenbacher-api-ingredients-gmbh-party-content-89424.pdf

    https://www.pharmacompass.com/pdf/party/content/tiefenbacher-api-ingredients-gmbh-party-content-96648.pdf

    https://www.pharmacompass.com/pdf/party/content/tiefenbacher-api-ingredients-gmbh-party-content-97507.pdf

    https://www.pharmacompass.com/pdf/party/content/tiefenbacher-api-ingredients-gmbh-party-content-987.pdf

NEWS #PharmaBuzz

read-more
read-more

https://tiefenbacher-pharmaceuticals.com/2024/05/08/tiefenbacher-api-ingredients-offers-custom-synthesis-of-intermediates-apis/

PRESS RELEASE
08 May 2024

https://tiefenbacher-pharmaceuticals.com/2024/04/08/tiefenbacher-group-welcomes-new-coo-sandip-tarate/

PRESS RELEASE
08 Apr 2024

https://tiefenbacher-pharmaceuticals.com/2024/03/19/tiefenbacher-group-awarded-ecovadis-silver-medal/

PRESS RELEASE
19 Mar 2024

https://tiefenbacher-pharmaceuticals.com/2023/09/27/launch-tiefenbacher-pharmaceuticals-generic-version-teriflunomide/

PRESS RELEASE
27 Sep 2023

https://tiefenbachergroup.com/2023/05/10/successful-approval-of-manufacturing-and-laboratory-facilities-by-saudi-food-and-drug-authority/

PRESS RELEASE
10 May 2023

https://tiefenbachergroup.com/2023/03/14/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-the-antihistamine-bilastine-for-a-market-entry-as-over-the-counter-otc-medicine-in-germany/

PRESS RELEASE
14 Mar 2023